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Interpretive Summary: 1 
Induced hyperketonemia affects the mammary immune response during 2 
lipopolysaccharide challenge in dairy cows. By Zarrin et al. Effects of an induced 3 
hyperketonemia through beta-hydroxybutyrate (BHBA) infusion and an additional 4 
intramammary lipopolysaccharide (LPS) challenge on immune response in liver and 5 
mammary gland were studied in mid-lactating dairy cows. BHBA infusion caused increased 6 
acute phase protein mRNA abundance in the mammary gland but not in the liver. The LPS-7 
related increase of somatic cell counts (SCC) was less pronounced whereas mRNA abundance 8 
of IL-8, IL-10 increased more in the response to LPS in the group receiving BHBA infusion 9 
than the control animals. The results demonstrate that elevated BHBA has most likely a direct 10 
effect on the susceptibility of mastitis. 11 
 12 
HYPERKETONEMIA AFFECTS IMMUNE RESPONSE IN DAIRY COWS 13 
 14 
Induced hyperketonemia affects the mammary immune response during 15 
lipopolysaccharide challenge in dairy cows 16 
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ABSTRACT 33 
Metabolic adaptations during negative energy and nutrient balance in dairy cows are supposed 34 
to cause impaired immune function and hence increased risk of infectious diseases including 35 
mastitis. Characteristic adaptations mostly occurring in early lactation are an elevation of 36 
plasma ketone bodies and free fatty acids (NEFA) and diminished glucose concentration. The 37 
aim of this study was to investigate effects of elevated plasma beta-hydroxybutyrate (BHBA) 38 
at simultaneously even or positive energy balance and thus normal plasma NEFA and glucose 39 
on factors related to the immune system in liver and mammary gland of dairy cows. In 40 
addition, the effect of elevated plasma BHBA and intramammary lipopolysaccharide (LPS) 41 
challenge on the mammary immune response was investigated. Thirteen dairy cows were 42 
either infused with BHBA (HyperB, n=5) to induce hyperketonemia (1.7 mmol/L), or with a 43 
0.9 % saline solution (NaCl, n=8) for 56 h. Two udder quarters were injected with 200 μg 44 
LPS after 48 h of infusion. Rectal temperature (RT) and somatic cell counts (SCC) were 45 
measured before, at 48 h after the start of infusions, and hourly during LPS challenge. The 46 
mRNA abundance of factors related to the immune system was measured in hepatic and 47 
mammary tissue biopsies one week before, and 48 h after the start of the infusion, and in 48 
mammary tissue additionally at 56 h of infusion (8 h after LPS administration). At 48 h of 49 
infusion in HyperB, the mRNA abundance of serum amyloid A (SAA) in the mammary gland 50 
was increased (P<0.01), and that of haptoglobin (Hp) tended to be increased (P= 0.07). 51 
Rectal temperature, SCC, and mRNA abundance of candidate genes in the liver were not 52 
affected by the BHBA infusion until 48 h. During the following LPS challenge RT and SCC 53 
increased in both groups (P<0.01). However, SCC increased less in HyperB than in NaCl 54 
(P<0.01). Quarters infused with LPS showed a more pronounced increase of mRNA 55 
abundance of IL-8, IL-10 in HyperB than in NaCl (P<0.05). The results demonstrate that an 56 
increase of plasma BHBA up-regulates acute phase proteins in the mammary gland. In 57 
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response to intramammary LPS challenge elevated BHBA diminishes the influx of leukocytes 58 
from blood into milk possibly via modified cytokine synthesis. Results indicate that increased 59 
ketone body plasma concentrations may play a crucial role in the higher mastitis susceptibility 60 
in early lactation.   61 
 62 
INTRODUCTION 63 
Since decades dairy cows have been selected for high milk production. Concurrently with the 64 
increase in milk production, the incidence of infectious diseases increased (Simianer et al., 65 
1991; Syvajarvi at al., 1986; Uribe at al., 1995). Mainly during the first weeks of lactation 66 
cows experience an immunosuppression and high susceptibility of infectious diseases (Smith 67 
et al., 1985; Hogan et al., 1989; Goff, 2006) which is supposed to be due to the metabolic 68 
adaptations to negative energy balance (NEB) (Suriyasathaporn et al., 2000; van Dorland., 69 
2009). Low plasma glucose concentrations, and elevated plasma NEFA and ketone body 70 
concentrations, specifically of BHBA, are the characteristic changes during NEB (Bobe et al., 71 
2004; van Dorland et al., 2009; Gross et al., 2011). Increased plasma BHBA concentrations 72 
above 1200 µmol/L are considered as a metabolic disorder (Ospina et al., 2010) defined as 73 
subclinical ketosis (Duffield et al., 2009). 74 
The occurrence of mastitis is determined by a number of pathogen, animal, and environmental 75 
factors (Burvenich et al., 2007). Among the animal factors high plasma BHBA concentration 76 
has negative influence on the susceptibility of mastitis and course of disease (Heyneman et 77 
al., 1990; Van Werven et al., 1997; Oltenacu and Ekesbo 1994). In vitro, growth of bacteria 78 
obtained from LPS-challenged quarters in hyperketotic and normal dairy cows showed that 79 
high plasma BHBA concentrations had a high positive correlation with the severity of mastitis 80 
induced by alive E. coli (Kremer et al., 1993). In addition, elevation of plasma BHBA 81 
concentration decreased in vitro chemotaxis and microbial killing in human (McMurray et al., 82 
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1990) as well as respiratory burst activity of bovine neutrophils (Hoeben et al., 1997). 83 
Cytokine production was reduced after bacterial infection in ketotic dairy cows (Kandefer-84 
Szerszen et al., 1992; Filar et al., 1992). However, elevated BHBA occurs mostly 85 
concomitantly with other metabolic and endocrine changes (Kessel et al., 2008; Gross et al., 86 
2011), and the immunosuppressive effect cannot be exclusively ascribed to the ketone bodies. 87 
Results of exclusive BHBA effects on the immune system are available from in vitro studies. 88 
Thus, in the presence of BHBA a decreased phagocytotic activity of milk polymorphonuclear 89 
leukocytes was demonstrated (Klucinski et al., 1988), as well as a reduced chemotactic 90 
capacity of bovine blood leukocytes (Suriyasathaporn et al., 1999). The role of BHBA in the 91 
immunosuppression in vivo is not fully understood (Burton et al., 2005). Information about 92 
the effects of hyperketonemia isolated from other metabolic changes on the immune response 93 
and SCC in hyperketotic cows is rare, and the effects of long term hyperketonemia have not 94 
been investigated in dairy cows. The objective of this work was to investigate effects of a 48 h 95 
elevation of plasma BHBA through BHBA infusion on parameters related to the immune 96 
system in liver and mammary gland, and to study the mammary immune response to LPS 97 
challenge during elevated BHBA for additional 8 h.  98 
 99 
MATERIAL AND METHODS 100 
Animals and Management  101 
All procedures involving animals followed the Swiss Animal Protection Law and were 102 
approved by the Federal Veterinary Office in Switzerland. Thirteen non pregnant Holstein 103 
dairy cows in diestrus with a parity of 3.5 ± 0.10, at 28 ± 0.3 (MEAN ± SD) weeks in milk 104 
were selected. Cows in mid lactation were chosen as the best possible model for investigation 105 
of the specific effect of BHBA infusion without the comprehensive endocrine and metabolic 106 
changes that occur during the period of highest milk production in early lactation. The cows 107 
were free of mastitis and other infectious diseases which was confirmed by a routine blood 108 
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glutaraldehyde coagulation test (Sandholm, 1976), and by measuring milk SCC (DeLaval cell 109 
counter DCC, DeLaval International AB, Tumba, Sweden), which had to be less than 150 x 110 
10
3
 cells/mL in all four quarters at the start of the experiment. The validity and repeatability 111 
of Delaval cell counter was previously shown (Sarikaya and Bruckmaier, 2006). 112 
Animals were moved to the experimental tie stall for adaptation to housing and feeding 113 
conditions two weeks before the start of the experiment. Both groups were fed ad libitum with 114 
hay (dry matter [DM] content, 890g/kg of fresh matter [FM]; on DM basis, consisting of 153 115 
g of crude protein [CP]/kg, 235.0 g of crude fiber [CF]/kg, and 5.7 MJ of NEL/kg). In 116 
addition they received a protein- and energy-rich concentrate (23.5% barley, 14.0% oats, 117 
20.0% wheat bran, 17.0% soybean expeller, 15.0% linseed meal, 0.6% salt, 2.2% carbonate of 118 
lime, 0.4% calf rearing feed premix , 4.0% molasses and 3.0% by pass fat, DM content, 881 119 
g/kg of FM; on DM basis, consisting of 217 g of CP/kg, 73.9 g of CF/kg, and 7.6 MJ of 120 
NEL/kg) twice daily according to individual milk production. In addition, minerals (50 g/ 121 
cow) were supplied once a day. Animals had access to fresh water ad libitum. Milking was 122 
performed twice daily at 0530 h and 1600 h.  123 
 124 
Experimental design and treatments 125 
Cows were randomly allocated to one of two infusion treatment groups as described earlier 126 
(Zarrin et al., 2013). In brief the treatments involved an intravenous Na-DL-β-OH-butyrate 127 
infusion to obtain plasma BHBA concentration between 1.5 to 2.0 mmol/L (HyperB, n=5) 128 
comparable to those in spontaneous hyperketonemia, and a saline (0.9 %) infusion (NaCl, 20 129 
mL/h, n=8) as control group. One day before the infusions started, cows were fitted with 130 
indwelling intravenous catheters (Cavafix® Certo® Splittocan®, B. Braun Melsung AG, 131 
Germany) with a length of 32 cm and a diameter of 16 G in both jugular veins. The infusions 132 
started at 0900 on day 1 and continued to 1700 two days later. At 48 h of infusions, each of 133 
two udder quarters was injected with 200 µg of LPS Escherichia coli serotype 026:B6 (# 134 
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L8274; Sigma-Aldrich) as LPS quarter, and 0.9 % NaCl solution were injected in two udder 135 
quarters as control. Details were described by Vernay et al. (2012). 136 
Data collection and sampling 137 
Blood samples. Baseline blood samples at 1 wk and at 2 h before the start of the infusion were 138 
taken between milking and feeding at 0730 h. Sampling was continued at least hourly during 139 
the 56 h infusion period. During the experimental infusions blood samples were obtained 140 
from the contralateral jugular catheter, which was not used for the infusion, by using tubes 141 
containing tri-potassium-EDTA. Plasma was separated by centrifugation at 3000 x g for 20 142 
minutes, and stored at -20 °C until analyses. Every 15 min during the first 2 h and every hour 143 
during the entire infusion period additional small blood samples (1mL) were analyzed 144 
immediately for adjustment of BHBA infusion rates at achieve and maintain the intended 145 
plasma concentration.  146 
Rectal temperature. Rectal temperature was measured during the adaptation period, 147 
immediately before the start of infusions, two days after the start of infusion, and hourly 148 
during the LPS challenge (8 h).  149 
Milk samples. Foremilk samples (~50 ml) were obtained before morning milking, after teat 150 
cleaning from both front quarters (one challenged with LPS and one control) during the 151 
adaptation period, immediately before the start of infusion, two days after the start of infusion 152 
and hourly during the LPS challenge (8 h). Milk SCC was measured with a DeLaval cell 153 
counter (DeLaval International AB, Tumba, Sweden) immediately after sampling.  154 
Udder biopsies. One week before the start of infusions, 48 h after the start of the infusions 155 
(before LPS challenge), and at the end of experiment (56 h) udder tissue biopsies were taken 156 
from the two rear quarters. Before the biopsies cows were sedated by an intravenous injection 157 
of 16 µg/kg of BW of xylazine (Xylazin Streuli ad us. Vet.; G. Streuli & Co. AG, Uznach, 158 
Switzerland). Udder tissue (30 to 60 mg) was obtained under local anesthesia with 10 mL 159 
Lidocain 2% (Streuli Pharma AG, Uznach), using a biopsy needle with a 12 G and 10 cm 160 
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(Bard
®
 Magnum
®
 Core Tissue Biopsy Needle, Türkenfeld, Germany). The samples were 161 
placed immediately into RNA stabilization reagent (RNAlater
®
, Ambion, Applied 162 
Biosysthems, Austin, TX), kept at +4 °C for 24 h, and stored at –80 °C until RNA extraction.  163 
Liver biopsies. Liver tissue (60 to 100 mg) was taken one week before the infusions and at 48 164 
h after the start of infusions, under local anesthesia with 10 mL Lidocain 2% (Streuli Pharma 165 
AG, Uznach) as described previously (Zarrin et al., 2013), the samples were kept at +4 °C for 166 
24 h in RNA stabilization reagent (RNAlater
®
, Ambion, Applied Biosysthems, Austin, TX), 167 
and stored at –80 °C until RNA extraction. 168 
 169 
Laboratory procedures 170 
Udder and liver tissue. Total RNA was extracted from udder and liver tissues with peq GOLD 171 
TriFast™ (PEQLAB Biotechnologie GmbH, Erlangen, Germany) according to the 172 
manufacturer’s protocol. Quantity and purity of RNA was measured by using NanoDrop ND-173 
2000 spectrophotometer (NanoDrop Technologies Inc., Wilmington, DE) at 260 nm and 280 174 
nm absorbance waves. Complementary DNA (cDNA) was made by reverse transcription of 175 
one μg of total RNA with Moleney Murine Leukemia Virus Reverse Transcriptase RNAase H 176 
Minus, Point Mutant (MMLV-RT; Promega Corp., Madison, WI) and random hexamer 177 
primers (Invitrogen, Leek, The Netherlands). The mRNA abundances of housekeeping genes 178 
(glyceraldehyde 3-phosphate dehydrogenase [GAPDH] and ubiquitin) and target genes related 179 
to immune response were measured by real-time quantitative PCR (qPCR) in a Rotor-Gene 180 
6000 rotary analyzer (Corbett Research, Sydney, Australia) and software version 1.7.75, using 181 
a master mix consisting of 0.8 μL PCR water, 1.0 μL forward primer (5 pmol), 1.0 μL reverse 182 
primer (5 pmol), and 5.2 μL 2x SensiMix plus SYBR-Green. The cycle threshold (CT) values 183 
obtained for candidate genes were adjusted according the mean of the housekeeping genes CT 184 
according to the following equation: ΔCT = CT (arithmetic mean of housekeeping genes) – 185 
CT (target gene). Differences in mRNA abundance during 48 h BHBA infusion in udder and 186 
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liver were calculated according to the following equation:  ΔΔCT = ΔCT [d 2 (48 h)] – ΔCT 187 
[d 0 (0 h)]. Differences in mRNA abundance during LPS challenge were calculated for LPS 188 
and control quarters separately according to this equation: ΔΔCT = ΔCT [d 3 (8 h)] – ΔCT [d 189 
3 (0 h)], as described by Vernay et al. (2012). The primer sequences for housekeeping and 190 
candidate genes were used according to previous publications: GAPDH, IL-8, SAA, and 191 
tumor necrosis factor-alpha (TNFα) (Wellnitz et al., 2006), ubiquitin, lactoferrin, and 192 
inducible nitric oxide synthase (iNOS) (Schmitz et al., 2004), nuclear factor kappa-light-193 
chain-enhancer of activated B cells (NF-κB) (Bruckmaier and Meyer, 2005), Hp (Hiss et al., 194 
2004), and IL-1β (Griesbeck-Zilch et al., 2008). The selected and measured genes, the used 195 
primer sequences, and PCR conditions are shown on Table 1.  196 
 197 
Statistical analysis 198 
Data are presented as means ± SEM and differences were considered significant if P < 0.05, 199 
and as a tendency if P < 0.10. 200 
Differences between before and after 48 h BHBA infusion and before and after LPS challenge 201 
(delta) were calculated for all recorded parameters. Somatic cell counts were analyzed and are 202 
shown at logarithmic scale (log10) to ensure normal distribution of data. Area under the curve 203 
was calculated for RT and SCC during the LPS challenge (8 h). Mammary mRNA abundance 204 
data were analyzed by using the general linear models (GLM) procedure of SAS (SAS 205 
Institute Inc., Cary, NC, USA, 2002-2008, Release 9.2), including treatment (BHBA or NaCl) 206 
as fixed effect. Differences between means were evaluated by the Tukey’s test. In addition, 207 
means of delta values obtained within each treatment were tested for differences from “0”. 208 
Differences in SCC, and RT between treatments within each time point and between time 209 
points within treatments were evaluated by using the ANOVA mixed model procedure of 210 
SAS, including treatment (BHBA or NaCl), time, and their interactions as fixed effects and 211 
cows as repeated subject.  212 
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 213 
RESULTS 214 
 215 
As reported earlier the mean infusion rate of BHBA during 48 h was 8.1 ± 0.3 µmol/kg/min, 216 
and plasma BHBA concentration was maintained at 1.7 ± 0.1 mmol/L in the HyperB group 217 
(Zarrin et al., 2013).  In the control group plasma BHBA concentration was 0.6 ± 0.1 mmol/L. 218 
In response to LPS administration at 48 h of infusion, plasma BHBA started to decrease 219 
(P<0.01) and the infusion had to be increased (P<0.001) to 11.1 ± 1.0 µmol/kg/min to 220 
maintain hyperketonemia (Figure 1). Despite increased BHBA infusion rate after LPS 221 
administration mean plasma BHBA concentration after LPS challenge (8 h) was not fully 222 
maintained and was 1.4 ± 0.1 mmol/L in HyperB. Also in the control group plasma BHBA 223 
decreased (P<0.01) after LPS administration (0.4 ± 0.1 mmol/L).  224 
 225 
Somatic cell counts and rectal temperature 226 
Beta-hydroxybutyrate infusion did not affect RT and milk SCC during 48 h of BHBA 227 
infusion (before LPS challenge; data not shown). The subsequent intramammary LPS 228 
challenge caused a significant increase in SCC in LPS challenged quarters compared to 229 
control quarters in both groups within 3 h after LPS administration (Figure 2). The increase of 230 
SCC was lower in the HyperB group than in the control group (P<0.01). In response to LPS 231 
challenge RT increased similarly in both groups from 38.6 ± 0.0
 º
C and 38.1 ± 0.2 
º
C to a 232 
maximum of 40.5 ± 0.2
 º
C and 40.8 ± 0.1
 º
C to be reached at 6 h and 5 h after LPS 233 
administration in HyperB and NaCl, respectively.  234 
 235 
Changes of mRNA abundance during BHBA infusion in liver and mammary tissue before 236 
LPS challenge 237 
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Changes of mRNA abundance of candidate genes related to immune response in liver and 238 
mammary tissue are shown on table 2. During 48 h of infusion the mRNA abundance of SAA 239 
and Hp in the liver increased similarly in both groups. 240 
In mammary tissue the mRNA abundance of SAA increased during the 48 h of infusion in 241 
HyperB (P<0.01) but not in the control group. Haptoglobin mRNA abundance tended to 242 
increase in HyperB compare to control group (P= 0.07). The mRNA abundance of the other 243 
measured candidate genes in the mammary gland did not change during the first 48 h of 244 
BHBA and NaCl infusion. 245 
 246 
Changes of mRNA abundance in mammary tissue in response to LPS challenge  247 
Changes of mRNA abundance of candidate genes in mammary tissue related to the immune 248 
response to LPS are shown on table 3. Intramammary LPS challenge caused an increased 249 
mRNA abundance of IL-1β, IL-6, IL-8, IL-10, TNFα, iNOS, NF-κB, Hp, and SAA in the LPS 250 
challenged quarters in both treatment groups. The mRNA abundance of IL-6, IL-10, and Hp 251 
increased also in the control quarters in both treatment groups. In the HyperB group the 252 
increase of mammary mRNA abundance in quarters with LPS administration was more 253 
pronounced than in the control group for IL-8 (P<0.01) and IL-10 (P<0.05), respectively.  254 
 255 
 256 
DISCUSSION 257 
To the best of our knowledge, the present experiment is the first study to investigate the 258 
effects of long term hyperketonemia through BHBA infusion on SCC and immune response 259 
in dairy cows that were stimulated with intramammary E. coli LPS.  260 
Unchanged SCC in milk during 48 h of increased BHBA concentrations in blood in the 261 
present study was in contrast to a previous study (Duffield et al., 1998) that reported an 262 
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association between hyperketonemia and increased SCC after parturition in dairy cows. 263 
However, the BHBA infusion represented an additional energy source during already positive 264 
energy balance in the present study as compared to the NEB that was reported in the 265 
mentioned study. In addition, in the present study the induced hyperketonemia by BHBA 266 
infusion was completely different to spontaneous hyperketonemia during NEB that is 267 
accompanied by low plasma glucose concentration and high plasma NEFA concentration after 268 
parturition (Kessel et al., 2008; van Dorland et al., 2009; Gross et al., 2011).   269 
Consistently with previous studies LPS challenge caused the increase of body temperature 270 
(Schmitz et al., 2004; Vernay et al., 2012) and milk SCC (Wellnitz et al., 2011; Vernay et al., 271 
2012). The induced increase of RT confirmed that LPS challenge caused not only a local 272 
activation of the immune response but had also a systemic effect (Dinarello, 1991). An 273 
increase of SCC is accepted as an indicator of inflammatory responses in the mammary gland 274 
(Schukken et al., 2003; Pfaffl et al., 2003; Wellnitz et al., 2011). Interestingly, the increase of 275 
milk somatic cells was less pronounced in LPS quarters in HyperB than the control group. 276 
This is supported by earlier in vitro studies that illustrated that elevation of BHBA 277 
concentration decreased neutrophil chemotactic response in bovine milk leukocytes in vitro 278 
(Cerone et al., 2007; Klucinski et al., 1988). Therefore, it can be assumed that the diminished 279 
increase of SCC in the present study in the HyperB group compared to the control group is 280 
related to the negative effects of plasma BHBA concentration on neutrophil recruitment.  281 
Increased hepatic mRNA abundance of SAA and Hp in both treatment groups during 48 h 282 
BHBA infusion indicates that the changes are induced by the experimental procedures 283 
independent of the applied treatment. It is possible that an increase of SAA and Hp mRNA 284 
abundance in the liver is related to experimental stress in both treatment groups. The long 285 
term BHBA infusion did not specifically affect hepatic mRNA abundance of these candidate 286 
genes. This finding is in agreement with a previous study which illustrated that ketosis does 287 
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not affect hepatic Hp and SAA mRNA abundance in dairy cows (Loor et al., 2007), and is in 288 
contrast to a study that documented increased serum Hp concentration during ketosis 289 
(Stengärde et al., 2008). In contrast to the liver, SAA mRNA abundance in mammary tissue 290 
was increased by long term BHBA infusion, and Hp tended to increase in HyperB compared 291 
to NaCl during 48 h BHBA infusion in the present study. The different effects of BHBA 292 
infusion on SAA and Hp mRNA abundance in the mammary tissue is most likely related to a 293 
higher sensitivity of SAA than Hp (Gruys et al., 1993; Alsemgeest et al., 1994; Werling et al., 294 
1996). It can be speculated that the different effect of high plasma BHBA concentration (48 h) 295 
on acute phase protein mRNA abundance in the liver and in the udder was related to the role 296 
of the liver in the systemic immune response whereas the udder tissue acts mainly locally 297 
within the organ. 298 
Increased SAA and Hp mRNA abundance in mammary tissue in response to LPS challenge 299 
confirms previous studies that illustrated increased synthesis of SAA (Wellnitz and Kerr, 300 
2004; Bruckmaier and Meyer, 2005; Vernay et al., 2012) and Hp (Hiss et al., 2004) in 301 
mammary tissue in response to LPS. Increased udder mRNA abundance of IL-1β, IL-6, 302 
iNOS, and TNFα, in quarters that were stimulated by intramammary LPS challenge in both 303 
groups is related to immune system activation and was documented in previous studies 304 
(Bruckmaier and Meyer, 2005; Wellnitz et al., 2011; Vernay et al., 2012; Hiss et al., 2004). 305 
This result demonstrates that increased BHBA concentrations in blood by infusions affect the 306 
abundance of measured genes related to immune response in the udder but no in the liver. 307 
Increased IL-6, IL-10, and Hp mRNA abundance in LPS quarters and control quarters in both 308 
treatment groups illustrated that intramammary LPS stimulation has also an influence on 309 
systemic immune response (Schmitz et al., 2004). Modified plasma BHBA concentration 310 
induced a more pronounced increase of IL-8 and IL-10 mRNA abundance compared to the 311 
control group, in LPS challenged quarters. There is a lack of information about effects of 312 
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hyperketonemia on mRNA abundance related to immune response. However, there is 313 
evidence that ketone bodies, specifically acetoacetate, increases IL-8, and IL-6 concentration 314 
in human U937 and THP-1 monocyte cell lines and human umbilical vein endothelial cells, 315 
while the presence of BHBA does not affect these cytokine concentrations (Rains et al., 2011; 316 
Jain et al., 2007). IL-8 is a chemokine that is produced by lymphocytes (Gregory et al., 1988), 317 
neutrophils (Strieter et al., 1990), and epithelial cells (Skansen-Saphir et al., 1993). IL-8 is 318 
involved into the recruitment of neutrophils and activates them (Harda et al., 1994) during 319 
mastitis (Barber and Yang, 1998) and mammary epithelial cells secrete IL-8 in response to 320 
LPS (Wellnitz and Kerr, 2004). It can be hypothesized that increased IL-8 mRNA abundance 321 
after LPS challenge is related to its role in the recruitment of immune cells from blood into 322 
milk. As BHBA infusion decreased neutrophil recruitment, the immune system was most 323 
likely forced to compensate the deficiency of BHBA effects on immune cell recruitment 324 
through the upregulation of IL-8 mRNA abundance. It seems that upregulation of IL-8, and 325 
IL-10 in HyperB group compared to the control group reflects negative effects of BHBA on 326 
the immune response.  327 
 328 
CONCLUSIONS 329 
The results of the present study demonstrate that a long term elevation of plasma BHBA (48 330 
h) affects acute phase proteins in the mammary gland but not in the liver. The immune 331 
response to LPS challenge is clearly affected by elevated BHBA plasma concentration what 332 
indicates that the frequently observed immunosuppression during spontaneous ketonemia in 333 
early lactation and hence increased susceptibility of mastitis during this period is most likely 334 
at least in part be directly caused by the elevated concentration of BHBA.  335 
 336 
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Figure legends 
 
Figure 1.   Beta-hydroxybutyrate (BHBA) infusion rates during 56 h infusion in cows 
infused with BHBA (HyperB). Plasma BHBA in cows infused with BHBA 
(HyperB) and cows infused with NaCl as control group (NaCl). Values 
represent Mean ± SEM. At 48 h of infusion two quarters of both treatment 
groups were challenged by intramammary LPS. 
 
 
Figure 2.   Somatic cell counts (in log10 scale) in milk after the LPS challenge. Data are 
means ± SEM in quarters that were challenged with intramammary E. coli 
lipopolysaccharide (LPS) and quarters that received NaCl (C), in cows that 
were infused with Beta-hydroxybutyrate (HyperB) and cows that were infused 
with NaCl as control group (NaCl). A, B, C, D and a, b, c, d, e: LPS quarters 
without common letter are significantly different (P<0.05) from base line 
(time 0 of LPS challenge) in HyperB and control group, respectively. 
Differences between SCC in LPS quarters (P<0.05) in HyperB and control 
group are indicated with (*). 
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Table 1. Polymerase chain reaction primer information (for = forward, rev = reverse), annealing 
temperature and the PCR product length 
Gene
1
 Sequence 5’-3’ 
Gene Bank  
accession no. 
Annealing  
temperature, 
(°C) 
Length
,bp 
GAPDH 
for GTC TTC ACT ACC ATG GAG AAG G 
NM001034034 60 197 
rev TCA TGG ATG ACC TTG GCC AG 
Ubiquitin 
for AGA TCC AGG ATA AGG AAG GCA T 
NM174133 62 198 
rev GCT CCA CCT CCA GGG TGA T 
IL-1β 
for AGT GCC TAC GCA CAT GTC TTC 
M37211 60 114 
rev TGC GTC ACA CAG AAA CTC GTC 
IL-6 
for CTTCACAAGCGCCTTCACTC 
NM_173923.2 62 132 
rev GTCAGAAGTAGTCTGCCTGG 
IL-8 
for ATG ACT TCC AAG CTG GCT GTT G 
AF232704 60 149 
rev TTG ATA AAT TTG GGG TGG AAA G 
IL-10 
for CCT GGA AGA GGT GAT GCC AC 
EU276074 60 133 
rev GTT TTC GCA GGG CAG AAA GCG 
iNOS 
for ACC TAC CAG CTG ACG GGA GAT 
U14640 62 316 
rev TGG CAG GGT CCC CTC TGA TG 
TNFα 
for CCA CGT TGT AGC CGA CAT C 
NM173966 60 155 
rev CCC TGA AGA GGA CCT GTG AG 
Lactoferrin 
for GGC CTT TGC CTT GGA ATG TAT 
L08604 62 338 
rev ATT TAG CCA CAG CTC CCT GGA G 
NF-κB 
for GCT GGA CCC AAG GAC ATG 
NM003998 56 235 
rev TGG TCT GCT GCA GAG CTG 
Hp 
for GTCTCCCAGCATAACCTCATCTC 
AJ271156 55 174 
rev AACCACCTTCTCCACCTCTACAA 
SAA 
for CCT GGG CTG CTA AAG TGA TC 
AF540564 57 184 
rev TAC TTG TCA GGC AGG CCA G 
1
GAPDH = glyceraldehyde 3-phosphate dehydrogenase; iNOS = inducible nitric oxide synthase; TNFα = 
tumor necrosis factor-alpha; NF-κB = nuclear factor kappa-light-chain-enhancer of activated B cells; Hp = 
haptoglobin; SAA = serum amyloid A. 
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Table 2. Changes of mRNA abundance of genes related to immune response in liver and udder tissue 
during infusion with beta-hydroxybutyrate (HyperB) or saline (NaCl) during 48h infusion. Delta 
(differences between before the start of the infusion and 48 h after the start of infusions). Values 
represent Mean ± SEM. 
Parameter
1# 
Group
2 
Delta 
ANOVA 
(P-Value, group) 
TNFα 
HyperB 0.4 ± 0.1 
0.52 NaCl 0.1 ± 0.4 
    
Hp 
HyperB 3.6 ± 1.3
* 
0.79 NaCl 4.0 ± 1.2
* 
    
SAA 
HyperB 2.5 ± 0.6
* 
0.45 NaCl 1.7 ± 0.7
* 
    
IL-1 β 
HyperB -0.5 ± 0.4 
0.32 NaCl 0.4 ± 0.6 
    
IL-6 
HyperB 0.6 ± 0.6 
0.12 NaCl -0.4 ± 0.3 
    
IL-8 
HyperB 0.6 ± 0.8 
0.47 NaCl 0.5 ± 0.8 
    
IL-10 
HyperB -0.3 ± 0.5 
0.17 NaCl 0.5 ± 0.3 
    
iNOS 
HyperB 0.1 ± 0.3 
0.45 NaCl 2.0 ± 1.9 
    
TNFα 
HyperB 0.7 ± 0.5 
0.38 NaCl 0.2 ± 0.3 
    
Lactoferrin 
HyperB 0.6 ± 0.3 
0.21 NaCl -0.1 ± 0.4 
    
NF-kB 
HyperB -0.4 ± 0.2 
0.64 NaCl -0.1 ± 0.4 
    
Hp 
HyperB 0.6 ± 0.4 
0.07 NaCl -0.3 ± 0.2 
    
SAA 
HyperB 1.4 ± 0.5
* 
<0.01 NaCl -0.7 ± 0.3 
    
1TNFα = tumor necrosis factor-alpha; Hp = haptoglobin; SAA = serum amyloid A; iNOS = inducible 
nitric oxide synthase; NF-κB = nuclear factor kappa-light-chain-enhancer of activated B cells;  
2
HyperB = Hyper beta-hydroxybutyrate group; NaCl = group of cows receiving physiological saline 
solution.  
#
parameters above the line are related to the liver tissue, and parameters below the line are related to 
the udder tissue.   
*Delta is different from 0 (P < 0.05). 
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Table 3.  mRNA abundance of genes related to immune responses in mammary gland of cows infused 
with beta-hydroxybutyrate (HyperB) or saline (NaCl) during the LPS challenge in LPS and control 
quarters. Values represent Mean ± SEM. 
 
Parameter
1 
Group
2 
LPS 
Delta (after LPS – 
before LPS) 
ANOVA 
(P-Value, 
group) 
NaCl 
Delta (after LPS – 
before LPS) 
ANOVA 
(P-Value, 
group) 
IL-1β 
HyperB 5.4 ± 0.9
* 
0.28 
1. 5 ± 1.1 
0.59 NaCl 2.9 ± 1.7
* 
0.7 ± 0.8 
       
IL-6 
HyperB 5.8 ± 1.2
* 
0.27 
2.2 ± 0.5
* 
0.75 NaCl 4.3 ± 0.6
* 
2.5 ± 0.6
* 
       
IL-8 
HyperB 10. 8 ± 0.6
* 
<0.01 
1.5 ± 0.7 
0.73 NaCl 6.5 ± 0.7
* 
2.1 ± 1.2 
       
IL-10 
HyperB 4. 6 ± 1.1
* 
0.05 
2.2 ± 0.6
* 
0.26 NaCl 2.3 ± 0.4
* 
1.2 ± 0.6
* 
       
iNOS 
HyperB 4.6 ± 0.5
* 
0.47 
-0.4 ± 0.4 
0.78 NaCl 4.3 ± 2.6
* 
-1.7 ± 6.1 
       
TNFα 
HyperB 2.7 ± 1.2
* 
0.9 
0.5 ± 0.9 
0.97 NaCl 2.5 ± 0.7
* 
0.4 ± 0.6 
       
Lactoferrin 
HyperB 1. 4 ± 1.1 
0.86 
0.8 ± 0.8 
0.81 NaCl 1.1 ± 0.7 0.6 ± 0.5 
       
NF-kB 
HyperB 1.7 ± 0.4
* 
0.45 
0.1 ± 0.5 
0.68 NaCl 2.3 ± 0.6
* 
-0.2 ± 0.6 
       
Hp 
HyperB 3.7 ± 0.6
* 
0.97 
 
1.4 ± 0.6
* 
0.15 NaCl 3.8 ± 1.1
* 
2.5 ± 0.4
*
 
       
SAA 
HyperB 5.1 ± 1.3
* 
0.78 
1.8 ± 1.6 
0.34 NaCl 5. 6 ± 1.1
* 
3.4 ± 0.7
* 
       
1
iNOS = inducible nitric oxide synthase; TNFα = tumor necrosis factor-alpha; NF-κB = nuclear factor 
kappa-light-chain-enhancer of activated B cells; Hp = haptoglobin; SAA = serum amyloid A.  
2
HyperB = Hyper beta hydroxybutyrate group; NaCl = group of cows receiving physiological saline 
solution. 
*Delta is different from 0 (P < 0.05). 
